The Cooper Companies Inc (COO) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket
 


The Cooper Companies Inc   (NASDAQ: COO)


The Cooper Companies Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is The Cooper Companies Inc 's ROA in the third quarter of 2026?
The Cooper Companies Inc achieved a return on average assets (ROA) of 4.57 % in its third quarter of 2026, which is below The Cooper Companies Inc 's average return on assets, which stands at 7.39%.

ROA has improved compared to 1.9% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 162 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 1803 to 1862.

What is ROA?



Return On Assets (Jul 31 2026)
III. Quarter
(Apr 30 2026)
II. Quarter
(Jan 31 2026)
I. Quarter
(Oct 31 2025)
IV. Quarter
(Jul 31 2025)
III. Quarter
Y / Y Total Assets Change 2.4 % 0.55 % 22.65 % 22.65 % 25.5 %
Y / Y Net Income Change 340.28 % - 25.41 % -28 % -6.11 %
Net Income (TTM) in million 570 236 401 375 408
Return On Assets (TTM) 4.57 % 1.9 % 3.24 % 3.17 % 3.62 %
COO's Total Ranking # 1862 # 1803 # 1589 # 1505 # 1504
Total Assets (TTM) in million 12,674 12,482 12,395 12,395 12,377
Seq. Total Assets Change 1.53 % 0.71 % 0 % 0.15 % -0.3 %
Seq. Net Income Change - - 54.61 % -13.94 % 12.09 %



Return On Assets Company Ranking
Within: No.
Industry # 44
Sector # 163
Overall # 1256

Return On Assets Statistics
High Average Low
36.34 %
7.39 %
1.9 %
(Jul 31 2021)   (Apr 30 2026)





Financial Statements
The Cooper Companies Inc 's Assets $ 12,674 million COO's Balance sheet
The Cooper Companies Inc 's Income $ 433 million Quarterly COO's Income Statement
COO's Income by Division See COO's Income by Division



Annual Return On Assets (Oct 31 2025)
FY 2025
(Oct 31 2024)
FY 2024
(Oct 31 2023)
FY 2023
(Oct 31 2022)
FY 2022
(Oct 31 2021)
FY 2021
Y / Y Total Assets Change 2.1 % 8.54 % 2.88 % 33.01 % 6.35 %
Total Assets in million 10,318 10,106 9,311 9,050 6,804
Y / Y Net Income Change -4.44 % 33.34 % -23.74 % -86.9 % 1135.19 %
Net Income in million 375 392 294 386 2,945
Annual Return On Assets 3.63 % 3.88 % 3.16 % 4.26 % 43.28 %




Comment on COO's ROA in the fiscal year ending 2025
In the fiscal year 2025 The Cooper Companies Inc 's ROA decreased compared to previous year to 3.63 %, due to deterioration of net income -4.44 % to $374.90 million, from $392.30 million a year ago, as COO's assets were $10,318.10 million.


More Return On Assets Ratios
COO's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
COO's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for COO's Competitors
Subscribers only: Roa for The Cooper Companies Inc 's Suppliers
Subscribers only: Return On Assets for COO's Customers

You may also want to know
COO's Roi COO's Inventory Turnover Ratio COO's Growth Rates COO's Dividend Comparisons
COO's Profitability Ratios COO's Asset Turnover Ratio COO's Dividend Growth
COO's Roe COO's Valuation Ratios COO's Financial Strength Ratios COO's Dividend Payout Ratio



Companies with similar Return On Assets at Jul 31 2026, within Healthcare Sector ROA
Transmedics Group Inc   12.50 %
Eton Pharmaceuticals Inc   12.37 %
Nephros Inc   12.30 %
Msa Safety Inc  12.23 %
Strata Critical Medical Inc   12.18 %
Insulet Corporation  12.13 %
Lantheus Holdings Inc   11.89 %
Ligand Pharmaceuticals Incorporated  11.68 %
Theravance Biopharma inc   11.68 %
Carlisle Companies Incorporated  11.62 %
Encompass Health Corporation  11.60 %
Protagonist Therapeutics inc   11.02 %
Agilent Technologies inc   10.97 %
Prestige Consumer Healthcare Inc   10.90 %
Lemaitre Vascular Inc   10.90 %
Ufp Technologies Inc   10.85 %
Progyny Inc   10.66 %
Regeneron Pharmaceuticals Inc   10.60 %
Johnson and Johnson  10.60 %
Tenet Healthcare Corp  10.49 %
Bristol myers Squibb Company  10.27 %
Solventum Corporation  10.13 %
Globus Medical Inc   10.04 %
Universal Health Services Inc   9.92 %
Entrada Therapeutics Inc   9.51 %
Amgen Inc   9.48 %
National Healthcare Corp  9.28 %
Tactile Systems Technology Inc   9.17 %
Bioventus Inc   9.08 %
Infusystem Holdings Inc  8.63 %


Date modified: 2026-09-11T09:38:45+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.